‘The conditions are ripe’: industry says it’s time for feds to consider a national bioeconomy strategy
By Jolson LimSep. 26, 2018
Canada once had a biotechnology strategy that, despite its flaws and poor execution, sent a signal that biotech firms should open up shop in Canada.
Industry advocates say it's time to consider a new biotechnology or bioeconomy strategy in an increasingly complex technological and regulatory environment. Photograph courtesy of Flickr
With Canada’s biotechnology sector showing signs of new growth, industry advocates say it’s time the federal government consider a national biotech strategy, more than a decade after one created in 1998 was nixed by the Conservative government.
People. Policy. Politics. This is an exclusive subscriber-only story.
Gerald Butts has removed himself from the daily political grind of strategizing how to keep the Liberals in power. But observers say it's unlikely he will be consigned to watch the campaign unfold from the sidelines.
SNC-Lavalin risks a takeover if it's convicted. But aside from likely outrage in Quebec, Ottawa can find other builders for its infrastructure plans if the company is banned from bidding on federal contracts, experts say
The Quebec company had extensive access to government ministers and top staffers, and was the only organization registered to lobby for allowing deferred prosecution agreements for white collar crimes.